Statins decreased aggression in adult men and increased aggression in postmenopausal women, according to a randomized, double-blind, placebo-controlled trial published online July 1 in PLOS One.

Some regions of the U.S., particularly in the South, are known for having high cardiovascular disease rates. Still, a study published in Annals of Internal Medicine on June 30 found at least three-quarters of people in each state had at least one cardiovascular risk factor.

Older women who have undergone menopause are less likely than men of a similar age to die from coronary heart disease (CHD), according to a prospective cohort study of more than 30,000 residents of 10 Southern states.

Creating the structured cardiac cath lab procedure report is the first step to improving patient care and data accuracy, coordinating intraprocedure workflow across the clinical team, making registry reporting seamless, and reducing overall cost of care.

Half of the cardiovascular deaths in U.S. adults in 2009 and 2010 were due to modifiable risk factors such as elevated cholesterol, diabetes, hypertension, obesity and smoking, according to a cross-sectional analysis of a large survey.

Young adults with elevated levels of blood pressure were more likely to have left ventricular systolic and diastolic dysfunction in middle age, according to a prospective study that tracked people over 25 years.

Physicians are making a case for statins and ARBs as a treatment for Ebola patients. They are not proposing the combination of drugs is a cure or preventive but rather an aid in survival to give patients time to build up immunity to the virus.

Approximately half of Hispanic and Latino adults in the U.S. were unaware they had high cholesterol and fewer than one-third received treatment for the condition, according to a cohort study in four geographically diverse communities.